ROYAL OAK -- Over the past two decades, cardiologists have explored many different treatments to help prevent permanent heart damage after a heart attack. One treatment that appears to be very ...
SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) ...
Henry Mayo Newhall Hospital is one of the first hospitals in Southern California to improve treatment of "widowmaker" heart ...
Results of a clinical trial demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening ...
IRVINE, Calif.--(BUSINESS WIRE)--TherOx, a ZOLL ® Medical company, announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO 2) Therapy at the upcoming Transcatheter ...
CHELMSFORD, Mass., October 31, 2022--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated ...
The Prebys Cardiovascular Institute in La Jolla is taking part in a nationwide clinical trial of a technique that uses supersaturated oxygen to reduce tissue damage suffered by heart attack patients, ...
TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized ...
Henry Mayo Newhall Hospital is one of the first hospital’s in Southern California to improve treatment of “widowmaker” heart attack patients with SuperSaturated Oxygen Therapy, the first and only ...
IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced it has received U.S. Food and Drug ...